Grin Therapeutics, Inc.
Clinical trials sponsored by Grin Therapeutics, Inc., explained in plain language.
-
New hope for rare genetic brain disorder: radiprodil trial targets seizures and symptoms
Disease control Recruiting nowThis study tests an experimental drug called radiprodil in about 100 people with GRIN-related neurodevelopmental disorder, a rare genetic condition that can cause seizures, developmental delays, and behavioral issues. The trial has two parts: first, participants are randomly assi…
Phase: PHASE3 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Liver function may change how this drug works – study seeks answers
Knowledge-focused Recruiting nowThis study looks at how the body processes a single dose of radiprodil in adults with mild, moderate, or severe liver problems compared to healthy adults. About 40 participants aged 18 to 75 will receive one 15 mg pill and be monitored for about 6 days. The goal is to see if live…
Phase: PHASE1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC